electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
Conference ID: 13722407
Webcast: electroCore 3Q21 Earnings Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Rich Cockrell CG Capital404-736-3838 email@example.com or Media Contact: Jackie DorskyelectroCore 908-313-6331 Jackie.firstname.lastname@example.org